BioSpace News Archive

Journal’s quarter-century of innovation, growth and cutting-edge research leads to special milestone

Hospitals experienced significant financial and operational harm fighting opioid crisis for two decades

DUBLIN, Feb. 04, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) announced today that it will report financial results for the third quarter of fiscal year 2020 on Tuesday, February 18, 2020. A news release will be issued at approximately 5:45 a.m. Central Standard Time (CST) and will be available at http://newsroom.medtronic.com .

Jupiter Medical Center is pleased to announce that it has received a 4-star rating for Overall Hospital Quality from the Centers for Medicare & Medicaid Services.

Qualigen, Inc., a privately-owned company focused on the development and commercialization of novel therapeutic products for the treatment of cancer and infectious diseases, as well as expansion of its flagship FastPack® diagnostic platform, announced today the issuance of U.S. Patent Number D865210, which covers advanced design aspects of Qualigen’s FastPack technology.

National Seating & Mobility, the leading provider of complex rehabilitation, mobility and accessibility solutions in North America, and the company’s international private equity owner, Cinven, are pleased to announce the appointment of former U.S. Senate Majority Leader William H. Frist, M.D. as a Special Advisor to the NSM Board of Directors.

Laminate Medical Technologies has announced the completion of enrollment into the VasQ™ External Support US Pivotal Study.

Arcutis Biotherapeutics, Inc. announced the closing of its initial public offering of 10,781,250 shares of its common stock at a price to the public of $17.00 per share, which includes 1,406,250 shares sold upon full exercise of the underwriters’ option to purchase additional shares of common stock.

Genomma Lab will report Fourth Quarter & Full Year 2019 Results on Wednesday, February 26, 2020 after the Mexican Market (BMV) close.

Globe Life Inc. (NYSE: GL) reported today that for the quarter ended December 31, 2019, net income was $1.69 per diluted common share, compared with $1.45 per diluted common share for the year-ago quarter.